申请人:Doherty James B.
公开号:US20100216761A1
公开(公告)日:2010-08-26
The invention is directed to novel azetidinones selected from 2-(S)-[4-(((2-(Dimethylamino)ethyl)ethylamino)carbonyl)phenoxy]-3,3-diethyl-N-[1-(R)-(4-(trifluoromethoxy)phenyl)butyl]-4-oxo-1-azetidin ecarboxamide, 2-(S)-[4-(((2-(Dimethylamino)ethyl)ethylamino)carbonyl)phenoxy]-3,3-diethyl-N-[1-(R)-(4-(trifluoromethyl)phenyl)butyl]-4-oxo-1-azetidinecarboxamide, and analogs thereof, and pharmaceutically acceptable salts thereof, and their use in the treatment of diseases associated with an excess of elastase, including emphysema, bronchial inflammation, chronic bronchitis, cystic fibrosis, acute respiratory distress syndrome, rheumatoid arthritis, osteoarthritis; glomerulonephritis, spondylitis, lupus, psoriasis, atherosclerosis, sepsis, septicemia, shock, myocardial infarction, reperfusion injury, and periodontitis.
本发明涉及从2-(S)-[4-(((2-(二甲基氨基)乙基)乙基氨基)羰基)苯氧基]-3,3-二乙基-N-[1-(R)-(4-(三氟甲氧基)苯基)丁基]-4-氧代-1-氮杂丁烷羧酰胺、2-(S)-[4-(((2-(二甲基氨基)乙基)乙基氨基)羰基)苯氧基]-3,3-二乙基-N-[1-(R)-(4-(三氟甲基)苯基)丁基]-4-氧代-1-氮杂丁烷羧酰胺及其类似物和药学上可接受的盐,以及它们在治疗与弹性蛋白酶过多相关的疾病中的应用,包括肺气肿、支气管炎症、慢性支气管炎、囊性纤维化、急性呼吸窘迫综合征、类风湿性关节炎、骨关节炎、肾小球肾炎、脊柱炎、狼疮、银屑病、动脉粥样硬化、败血症、脓毒症、休克、心肌梗死、再灌注损伤和牙周病。